Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes
A Phase 3, 24-Week, Multi-Center, Open-Label, Randomized, Controlled Trial Comparing the Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents (Metformin and a Secretagogue) in Subjects With Type 2 Diabetes Mellitus Sub-optimally Controlled on Combination Metformin and a Secretagogue.
1 other identifier
interventional
547
11 countries
120
Brief Summary
to demonstrate the efficacy of inhaled Technosphere/Insulin in combination with metformin versus combination metformin and a secretagogue
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3 diabetes-mellitus-type-2
120 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2004
CompletedFirst Submitted
Initial submission to the registry
May 31, 2006
CompletedFirst Posted
Study publicly available on registry
June 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2008
CompletedResults Posted
Study results publicly available
October 16, 2014
CompletedOctober 16, 2014
October 1, 2014
3.2 years
May 31, 2006
July 22, 2014
October 9, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Difference in Change From Baseline for HbA1c Between TI+ Metformin and Metformin+Secretagogue
Baseline to Week 12
Secondary Outcomes (2)
Difference in Change From Baseline for HbA1c Between TI Alone and Metformin+Secretagogue
Baseline to Week 12
Change in HbA1c From Baseline to Week 24 (Subjects Who Stayed on Original Treatment)
Week 24
Study Arms (3)
1
EXPERIMENTALTechnosphere Insulin
2
ACTIVE COMPARATORMetformin \& Secretagogues
3
EXPERIMENTALTechnosphere \& Metformin
Interventions
Metformin tablets,Secretagogues supplied as any of the currently marketed brands and formulations.
Technosphere Insulin Inhalation Powder 15U/30U, Metformin tablets
Eligibility Criteria
You may qualify if:
- Non-smokers with clinical diagnosis of Type 2 diabetes mellitus for \>or= to 6 months
- Stable regimen of metformin for \> or = to 1000mg/day or maximum tolerated dose) and a secretagogue \< or = 1/2 the maximum manufacturer-recommended daily dose without any dose adjustments within the preceding 6 wks.
- HbA1c \>or= to 7.5% and \< or= to 11.0%
- BMI \< or = to 40kg/m2.
- FEV1\> or = to 70%, Total Lung capacity and \> or =80% DLco \> or= to 70%
You may not qualify if:
- Treatment with any type of anti-diabetic therapy, other than metformin \& secretagogues within the preceding 12 weeks
- Serum creatinine \> 1.4mg/dL in female subjects and \>1.5mg/dL in male subjects
- History of chronic obstructive pulmonary disease, clinically proven asthma and/or any other clinically important pulmonary function testing and/or radiologic findings
- Evidence of serious complications of diabetes (e.g. autonomic neuropathy)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (120)
Radiant Research-Birmingham
Birmingham, Alabama, 35209, United States
Parkway Medical Center
Birmingham, Alabama, 35215, United States
Redpoint Research
Phoenix, Arizona, 85029, United States
Arizona Center for Clinical Research
Phoenix, Arizona, 85032, United States
International Clinical Research Network
Chula Vista, California, 91911, United States
National Jewish Medical & Research Center
Denver, Colorado, 80206, United States
Creekside Endocrine Associates
Denver, Colorado, 80209, United States
Jennifer Hone MD
Denver, Colorado, 80220, United States
Chase Medical Research, LLC
Waterbury, Connecticut, 06708, United States
Center for Diabetes & Endocrine Care
Hollywood, Florida, 33021, United States
International Research Associates LLC
Miami, Florida, 33156, United States
Cedar-Crosse Research Center
Chicago, Illinois, 60607, United States
John H Stoger Jr Hospital of Cook County
Chicago, Illinois, 60612, United States
Clintell Inc
Skokie, Illinois, 60076, United States
James A Dicke MDPA
Towson, Maryland, 21204, United States
East Coast Clinical Research Inc
Haverhill, Massachusetts, 01830, United States
Wayne State University
Detroit, Michigan, 48201, United States
Michigan Institute of Medicine
Livonia, Michigan, 48152, United States
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Clayton Medical Research
St Louis, Missouri, 63117, United States
Raidant Research-St Louis
St Louis, Missouri, 63141, United States
Creighton Diabetes Center
Omaha, Nebraska, 68131, United States
Lovelace Scientific Resources (Albuquerque)
Albuquerque, New Mexico, 87108, United States
Winthrop University Hospital
Mineola, New York, 11501, United States
North Shore Diabetes and Endocrine Associates
New Hyde Park, New York, 11042, United States
Metrolina Internal Medicine
Charlotte, North Carolina, 28204, United States
Charlotte Clinical Research Inc
Charlotte, North Carolina, 28211, United States
Sensenbrenner Primary Care
Charlotte, North Carolina, 28277, United States
Duke Medical Center
Durham, North Carolina, 27710, United States
Dayton Clinical Research
Dayton, Ohio, 45406, United States
Providence Health Partners - Center of Clinical Research
Dayton, Ohio, 45439, United States
Radiant Research
Portland, Oregon, 97239, United States
Upstate Pharmaceutical Research
Greenville, South Carolina, 29615, United States
Collierville Medical Specialists
Collierville, Tennessee, 38017, United States
Memphis Internal Medicine (Kathawala)
Memphis, Tennessee, 38119, United States
GoodLife Medical Center PLLC
Memphis, Tennessee, 38120, United States
Baylor Endocrine Center
Dallas, Texas, 75246, United States
Quality Assurance Research Center Inc
San Antonio, Texas, 78205, United States
Clinical Trials of Texas Inc
San Antonio, Texas, 78229, United States
Covenant Clinic Research
San Antonio, Texas, 78229, United States
Diabetes & Glandular Disease Research Assoc PA
San Antonio, Texas, 78229, United States
SAM Clinical Research Center
San Antonio, Texas, 78229, United States
Cedar Research
Tacoma, Washington, 98405, United States
Hospital Interzonal de Agudos Pedro Fiorito
Avellaneda, Buenos Aires, B1870ARG, Argentina
Centro Endocrinologic Tiempo
Buenos Aires, C1117ABH, Argentina
Hospital Italiano de Buenos Aires
Buenos Aires, C1181ACH, Argentina
Cons Asoc de Endocrinologia
Buenos Aires, C1425AGC, Argentina
CIMeL
Buenos Aires, Argentina
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
Hospital Sao Lucas da PUCRS
Porto Alegre, Rio Grande do Sul, 90610-000, Brazil
Ccbr Brasil Centro de Analises e Pesquisas Clinicas Ltda
Rio de Janeiro, 22271-100, Brazil
Hospital Guilherme Alvaro
Santos, 11045-904, Brazil
CPClin-Centro de Pesquisas Clinicas
São Paulo, 01244-030, Brazil
UNIFRSP
São Paulo, 04020-050, Brazil
Hospital do Rim e Hipertensao
São Paulo, 04025-011, Brazil
Instituto de Pesquisa Clinica e Medicina Avancada
São Paulo, 05437-010, Brazil
Quest Clinical Trials
Markham, Ontario, L6B 1A1, Canada
Lifestyle Metabolism Center
Oakville, Ontario, L6H 3P1, Canada
Lifestyle Metabolism Center
Thornhill, Ontario, L4J 8L7, Canada
Lifestyle Metabolism Center
Toronto, Ontario, M4R 2G4, Canada
Trial Management Group Inc (Henein
Toronto, Ontario, M4T 1N5, Canada
Unimedico Management
Richmond Hill, L4C 9M7, Canada
Hospital Padre Alberto Hurtado
Santiago, Santiago Metropolitan, Chile
Hospital Clinico Pontificia Universidad Catolica de Chile
Santiago, Chile
Hospital del Salvador
Santiago, Chile
Instituto de Informacion de Tramiento y Educacion en Salud
Santiago, Chile
Diabetologicka a interni ambulance
Ostrava-Kunčice, CZE, 70702, Czechia
Institute for Clinical and Exp Medicine
Prague, CZE, 140 21, Czechia
University Hospital Na Bulovce
Prague, CZE, 180 81, Czechia
Interní a diabetologická Outpatient
Ostrava, Ostrava, 70900, Czechia
Diabetologicka ambulance (Chmura)
Ostrava, 70200, Czechia
II interni klinika FN Kralovske Vinohrady
Prague, 10034, Czechia
Endokrinologicky ustav
Prague, 11694, Czechia
3rd Medical Department General Faculty Hospital
Prague, 12801, Czechia
Instituto Mexicano de Investigacion
Mexico City, Durango, 06700, Mexico
Hospital Universitario Dr Jose E Gonzalez
Monterrey, Nuevo León, 64460, Mexico
Hospital Santa Engracia-CIMA
Garza García, 66260, Mexico
Centro de Estudios en Diabetes
Mexico City, 01120, Mexico
Hospital General de Mexico Servicio EndocrinologiaJefe Del Servicio
Mexico City, 06726, Mexico
OCA-MIRC
Monterrey, 64020, Mexico
Klinika Endocrinologii Diabetologii I
Bialystock, POL, 15-276, Poland
NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny
Bialystok, POL, 15-435, Poland
Katedra I Klinika Chorob Metabolicznych Collegium Medicum Uniwersytety Jagiellonskiego
Krakow, POL, 31 501, Poland
Instytut Centrum Zdrowia (009) Matki Polki
Lodz, POL, 93-338, Poland
Spzital Kolejowy imm Wlodzimierza Roeflera
Pruszków, POL, 05-800, Poland
Oddzial Kliniczny Diabetologii (009) Kliniczny nr 1 im Norberta Barlickiego Uniwersytety Meycznego
Lodz, 90-153, Poland
Centrum Leczenia Chorob cywilizacyjnych
Warsaw, 02 777, Poland
Niepubliczny Zaklad Opieki Zdrowotnej VIVAMED
Warsaw, 03 580, Poland
NHI Kemerovo Regional Clinical Hospital
Kemerovo, RUS, 650061, Russia
NI Principal Military Clinical Hospital n a academician N.N. Burdenko of the Ministry of Defense
Moscow, RUS, 105229, Russia
NEI HPE Moscow State University of Medicine and Dentistry of FAHSD City Clinical Hospital #70
Moscow, RUS, 111399, Russia
NI Endrocrinological Research Centre of RAMS In patient replacing technologies department
Moscow, RUS, 115478, Russia
NI Moscow Regional Scientific Research Clinical Institute na MF Vladimirsky
Moscow, RUS, 129110, Russia
St Petersburg NHI City Polytclinic #77 City Diabetological Center #4
Saint Petersburg, RUS, 193012, Russia
Central Medical Sanitary Unit #122
Saint Petersburg, RUS, 194291, Russia
St Petersburg NHI Municipal Multi-Speciality Hospital # 2
Saint Petersburg, RUS, 194354, Russia
TUV Medico-Military Academy
Saint Petersburg, RUS, 198013, Russia
NEI HPE Smolensk State Medical Academy of FAHSD RNHI Smolensk Regional Clinical Hospital
Smolensk, RUS, 214018, Russia
MHI Clinical Hospital for Emergency Care na NV Soloviev
Yaroslavl, RUS, 150003, Russia
NHI Yaroslavl Regional Clinical Hospital
Yaroslavl, RUS, 150062, Russia
NI Central Clinical Hospital of RAS
Moscow, 117 593, Russia
Complejo Hospitalario Nuestra Senora de Valme
Seville, Andalusia, 41014, Spain
Hospital Clinic I Provincial
Barcelona, 08036, Spain
Hospital Universitario de la Princessa
Madrid, 28006, Spain
Hospital Ramon y Cajal
Madrid, 28034, Spain
Corporacion Sanitaria Parc Tauli Unidad de Endocrinologia
Sabadell, 08208, Spain
Bukovinian State Medical University Dept of Clinical Immun
Chernivtsy, UKR, 58022, Ukraine
Dniepropetrovsh State Medical Academy
Dniepropetrovsk, UKR, 49023, Ukraine
Donetsk State Medical University
Donetsk, UKR, 83003, Ukraine
Donetsk State Medical University (Chair of Immun Allergogoly & Endocrin)
Donetsk, UKR, 83099, Ukraine
Railway Clinical Hospital on Donetsk Station
Donetsk, UKR, 83114, Ukraine
Chair Family Med of National Med University
Kiev, UKR, 04050, Ukraine
Institute of Endocrinology and Metabolism
Kiev, UKR, 04114, Ukraine
Ukr Scientifically Practical Centre of Endocrine Surgery
Kiev, UKR, 2175, Ukraine
Odessa State Medical University Dept of Gen Practice and Med Rehab
Odesa, UKR, 65009, Ukraine
Odessa Reg. Clinical Hosp Outpatient Department
Odesa, UKR, 65025, Ukraine
Odessa State Med Dept of Family Med and Gen Practice
Odesa, UKR, 65039, Ukraine
Vinnitsa State Medical University
Vinnitsa, UKR, 21010, Ukraine
Outpatient Clinic of Family Physician "Rusanovka"
Kiev, 02147, Ukraine
Public Institution City Policlinic #20 Odessa
Odesa, 65114, Ukraine
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Wks 12-24 was a non-randomized treatment period of the trial; outcomes were not analyzed for Wks 12-24. Safety results include entire trial; patients counted in multiple treatments for safety.
Results Point of Contact
- Title
- Chief Medical Officer
- Organization
- MannKind Corporation
Study Officials
- STUDY DIRECTOR
For MannKind sponsored trials, the Overall Study Official is the Chief Scientific Officer
Mannkind Corporation
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2006
First Posted
June 1, 2006
Study Start
December 1, 2004
Primary Completion
March 1, 2008
Last Updated
October 16, 2014
Results First Posted
October 16, 2014
Record last verified: 2014-10